FUSEN PHARM 01652Hong Kong Stock Exchange

1.0158.56%( +0.080 )
Closed: Oct 9 · Delayed · Hong Kong Stock Exchange
FUSEN PHARM (01652) Company Profile - Company Info, Industry & Management - cibo

Company Information

Market
HKEX Main Board
Listing Date
2018-07-11
Industry
Innovative Drugs & Biologics
Fiscal Year End
Dec 31
ISIN
KYG370981030

Industry

Innovative Drugs & Biologics 0.02%
124 stocks in this industry
Down 52 Up 57
Industry RankingsValue (HKD)Rank
Revenue (Last FY)320.57M74/112
Net Profit (Last FY)-13.82M57/125
ROE (Last FY)-3.28%58/117

Change is the 2026-10-09 close against the previous close; the industry change is the equal-weighted average of its stocks. Sub-industry classification is maintained by cibo. Last FY is each company's latest annual report. Net profit is profit attributable to owners of the parent; ROE = net profit / closing equity attributable to owners. Non-HKD statements are converted at ECB reference rates.

About this page

This page shows FUSEN PHARM (01652) company information, related securities, the price change distribution and in-industry rankings within its sub-industry, and the board of directors. Quotes come from HKEX Daily Quotations, financial metrics from each company's latest annual report, and the director list from HKEXnews.